Medpace, Fortrea Cut as Jefferies Reviews CROs Amid Biotech Headwinds
IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock Right Now
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating
Truist Financial Gives a Buy Rating to IQVIA Holdings (IQV)
Overweight Quality Stocks With Positive EPS Revision - MS
Is Now The Time To Put IQVIA Holdings (NYSE:IQV) On Your Watchlist?
Sharp Sword! The FTC sues three major pharmaceutical 'middlemen', vowing to correct the distorted chain of interests.
①The USA FTC announced on its official website that it has filed a lawsuit against three major pharmaceutical benefit managers and their affiliated organizations, accusing them of engaging in anti-competitive and unfair rebate practices; ② The FTC also "explicitly stated" in the declaration that it is deeply concerned about the roles played by Eli Lilly, Novo-Nordisk, and Sanofi, insulin pharmaceutical companies, and may suggest in future enforcement actions to prosecute these pharmaceutical manufacturers.
A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs
IQVIA Holdings Is Maintained at Neutral by Baird
Baird Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $256
Express News | IQVIA Holdings Inc : Baird Raises Target Price to $256 From $251
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
ICON Draws Bullish View at Leerink on Business Model
IQVIA Holdings' (NYSE:IQV) Investors Will Be Pleased With Their Decent 52% Return Over the Last Five Years
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Goldman Thinks IQVIA Holdings Inc. (IQV) Is A Long-Term AI Stock Set To Rally Eventually
Is IQVIA Holdings Stock Underperforming the S&P 500?
Supernus Cut to Neutral at Piper Sandler on Qelbree Growth Trajectory
IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance With Its AI Solutions
(IQV) - Analyzing IQVIA Hldgs's Short Interest